SEC EDGAR Filing Information

Form 8-K -- Current report

Period of Report: 2008-07-09
Filing Date Changed: 2008-07-11
Documents: 1

SEC Accession No.
0000354507-08-000087
Filing date: 2008-07-11
Accepted: 2008-07-11 16:45:20

Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Table of submitted documents:

Seq	Type	Document	Size	Description
1	8-K	oncolintherapeutics8k.htm	100428	ONCOLIN THERAPEUTICS FORM 8K - V1 7-9-2008

		0000354507-08-000087.txt	102187	Complete submission text file

Filer Information:

Edgeline Holdings, Inc. (Filer) (0001229089)
IRS No.: 880507007 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-50541 | Film No.: 08949354
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
1330 POST OAK BLVD.
SUITE 1600
HOUSTON TX 77056
713 621-5208

Mailing Address
1330 POST OAK BLVD.
SUITE 1600
HOUSTON TX 77056